BLB&B Advisors, LLC
- SEC CIK
- 0001389059
- Latest filing
- Aug 5, 2026
IONS holding history
Ionis Pharmaceuticals Inc in every 13F filed by BLB&B Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
IONS overviewAll 13F holders of IONSFull Q2 2026 holdings
- Shares (Q2 2026)
- 28,570
- Value
- $2.27M
- % of portfolio
- 0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 28,570 | $2.27M | 0.1% | −6,600−18.8% | Reduced | Holders |
| Q1 2026 | 35,170 | $2.64M | 0.1% | −26,350−42.8% | Reduced | Holders |
| Q4 2025 | 61,520 | $4.87M | 0.2% | −57,080−48.1% | Reduced | Holders |
| Q3 2025 | 118,600 | $7.76M | 0.3% | −32,950−21.7% | Reduced | Holders |
| Q2 2025 | 151,550 | $5.99M | 0.3% | −650−0.4% | Reduced | Holders |
| Q1 2025 | 152,200 | $4.59M | 0.2% | +150+0.1% | Added | Holders |
| Q4 2024 | 152,050 | $5.32M | 0.3% | −200−0.1% | Reduced | Holders |
| Q3 2024 | 152,250 | $6.10M | 0.3% | −1,500−1.0% | Reduced | Holders |
| Q2 2024 | 153,750 | $7.33M | 0.4% | +7,650+5.2% | Added | Holders |
| Q1 2024 | 146,100 | $6.33M | 0.4% | −1,000−0.7% | Reduced | Holders |
| Q4 2023 | 147,100 | $7.44M | 0.5% | −550−0.4% | Reduced | Holders |
| Q3 2023 | 147,650 | $6.70M | 0.5% | −2,650−1.8% | Reduced | Holders |
| Q2 2023 | 150,300 | $6.17M | 0.4% | +1,340+0.9% | Added | Holders |
| Q1 2023 | 148,960 | $5.32M | 0.4% | 00.0% | Unchanged | Holders |
| Q4 2022 | 148,960 | $5.63M | 0.4% | −110−0.1% | Reduced | Holders |
| Q3 2022 | 149,070 | $6.59M | 0.5% | −180−0.1% | Reduced | Holders |
| Q2 2022 | 149,250 | $5.53M | 0.4% | −495−0.3% | Reduced | Holders |
| Q1 2022 | 149,745 | $5.55M | 0.4% | −1,190−0.8% | Reduced | Holders |
| Q4 2021 | 150,935 | $4.59M | 0.3% | −5,265−3.4% | Reduced | Holders |
| Q3 2021 | 156,200 | $5.24M | 0.3% | −1,290−0.8% | Reduced | Holders |
| Q2 2021 | 157,490 | $6.28M | 0.5% | +870+0.6% | Added | Holders |
| Q1 2021 | 156,620 | $7.04M | 0.6% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.